The manufacturer of the so-called EVO ICL Lens, a clear vision solution for nearsightedness which does not require contact lenses or glasses, has made inroads with its sales and market share in ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...

manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the third quarter ended ...

With the increasing demand for vision correction options like EVO ICL, which offers an alternative to LASIK for patients seeking clear vision without glasses or contact lenses, Porter ...

The company is renowned for its EVO Implantable Collamer Lenses (EVO ICL™), which have been sold in over 75 countries. In its latest earnings report, STAAR Surgical announced a robust financial ...

Eye care services offered at the practices include LASIK, EVO ICL, Refractive Lens Exchange, advanced corneal procedures and transplants, dry eye disease treatment, oculoplastic and aesthetic services ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia ...

LAKE FOREST, Calif., November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...